Protective associations between PTVs in IL33 and asthma; GSDMB and asthma; and IFIH1 and hypothyroidism represent particularly attractive drug targets, whereas risk associations between PTVs in FANCM and lung cancer and NOL3 and muscle injuries implicate these genes as important to the development of these conditions. The gene discussed is NOL3; the disease is asthma.